AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

STREPTOMYCIN SULPHATE

13 registrations across 4 African markets— 11 active

Markets with STREPTOMYCIN SULPHATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
STREPTOMYCIN SULPHATE ​ POWDER FOR SOLUTION FOR INJECTION🇬🇭GhanaactiveSept 2029
STREPTOMYCIN SULPHATE ​ POWDER FOR SOLUTION FOR INJECTION🇬🇭GhanaactiveSept 2029
STREPTOSOL
INJECTABLE; INJECTION
🇿🇼ZimbabweCAPS PVT LTDactiveDec 2027
SOLUSTREP
INJECTABLE; INJECTION
🇿🇼ZimbabweCAPS PVT LTDactiveDec 2027
STREPTOMYCIN
POWDER; ORAL
🇿🇼ZimbabweCAPS PVT LTDactiveDec 2027
STREPTOMYCIN 1G INJECTION
INJECTION
🇲🇼MalawiexpiredJun 2018
STREPTOMYCIN 1G INJECTION
INJECTION
🇲🇼MalawiexpiredJun 2012
STREPTOMYCIN SULPHATE
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaABACUS PHARMA (A) LTD.active
STREPTOMYCIN SULPHATE
PARENTERAL ORDINARY I M VIALS
🇺🇬UgandaSWISS PARENTERALS LTDactive
STREPTOMYCIN SULPHATE
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaABACUS PHARMA (A) LTD.active
STREPTOMYCIN SULPHATE
PARENTERAL ORDINARY I M VIALS
🇺🇬UgandaSWISS PARENTERALS LTDactive
STREPTOMYCIN SULPHATE
PARENTERAL ORDINARY I M VIALS
🇺🇬UgandaSWISS PARENTERALS LTDactive
STREPTOMYCIN SULPHATE
PARENTERAL ORDINARY I M VIALS
🇺🇬UgandaSWISS PARENTERALS LTDactive

STREPTOMYCIN SULPHATE in Africa — Regulatory Overview

STREPTOMYCIN SULPHATE is registered across 4 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Zimbabwe, Ghana, Malawi. AfricaRegulatory refreshes this data daily from official government sources.

Of the 13 registrations, 11 (85%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.